These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 204940)

  • 21. Common tumor-associated antigens of chemically induced mouse sarcomas expressing murine leukemia virus antigens by primary in vitro sensitization.
    Saito T
    Fukuoka Igaku Zasshi; 1984 Mar; 75(3):137-48. PubMed ID: 6088376
    [No Abstract]   [Full Text] [Related]  

  • 22. H-2 antigens and tumour-associated transplantation antigens in clones derived from a methylcholanthrene-induced BALB/c tumour: their influence on the generation in vitro and in vivo of the specific anti-tumour immune response.
    Pérez M; Garrido A; Algarra I; Caballero A; Delgado C; Collado MD; Fernández-Cruz E; Garrido F
    Exp Clin Immunogenet; 1989; 6(3):204-18. PubMed ID: 2631798
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Embryonic antigens shared between chemically induced lymphosarcomas and fibrosarcomas of the mouse.
    Ménard S; Colnaghi MI
    J Natl Cancer Inst; 1975 Feb; 54(2):479-81. PubMed ID: 1172784
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RNA tumor-virus antigen expression in chemically induced tumors. Virus-genome-specified common antigens detected by complement fixation in mouse tumors induced by 3-methylcholanthrene.
    Whitmire CE; Salerno RA; Rabstein LS; Huebner RJ; Turner HC
    J Natl Cancer Inst; 1971 Dec; 47(6):1255-65. PubMed ID: 4330465
    [No Abstract]   [Full Text] [Related]  

  • 25. Tumor-associated transplantation antigen distinct from H-2k-like antigens on a BALB/c (H-2d) fibrosarcoma.
    Parmiani G; Meschini A; Invernizzi G; Carbone G
    J Natl Cancer Inst; 1978 Nov; 61(5):1229-34. PubMed ID: 81882
    [No Abstract]   [Full Text] [Related]  

  • 26. Expression of alien H-2 specificities of a chemically induced BALB/c fibrosarcoma.
    Meschini A; Invernizzi G; Parmiami G
    Int J Cancer; 1977 Aug; 20(2):271-83. PubMed ID: 70414
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serologic evidence for cross-reacting antigens in two carcinogen-induced murine sarcomas.
    Fritze D; Kern DH; Waldman SR; Pilch YH
    Int J Cancer; 1975 Jan; 15(1):116-31. PubMed ID: 1079201
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of established transplants of chemically induced sarcomas in syngeneic mice by lymphocytes from immunized donors.
    Borberg H; Oettgen HF; Choudry K; Beattie EJ
    Int J Cancer; 1972 Nov; 10(3):539-47. PubMed ID: 4668494
    [No Abstract]   [Full Text] [Related]  

  • 29. Heterogeneity of MHC-class-I antigens in clones of methylcholanthrene-induced tumors. Implications for local growth and metastasis.
    Algarra I; Gaforio JJ; Garrido A; Mialdea MJ; Pérez M; Garrido F
    Int J Cancer Suppl; 1991; 6():73-81. PubMed ID: 2066185
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cross-reactive cellular and humoral immunity to carcinogen-induced chicken fibrosarcomas. I. Protective cross-immunity between transplantable tumor lines.
    Edelman AS; Xue B; Sanchez P; Thorbecke GJ
    J Immunol; 1985 Sep; 135(3):2206-12. PubMed ID: 3926898
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immune status of autochthonous and adoptively protected mice toward spontaneous and chemically induced tumors.
    Basombrío MA; Prehn RT
    Cancer Res; 1972 Nov; 32(11):2545-50. PubMed ID: 5082598
    [No Abstract]   [Full Text] [Related]  

  • 32. CD8+ T cells are crucial for the ability of congenic normal mice to reject highly immunogenic sarcomas induced in nude mice with 3-methylcholanthrene.
    Boesen M; Svane IM; Engel AM; Rygaard J; Thomsen AR; Werdelin O
    Clin Exp Immunol; 2000 Aug; 121(2):210-5. PubMed ID: 10931133
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro detection of cell-mediated immunity to individual tumor-specific antigens of chemically induced BALB/c fibrosarcomas.
    Carbone G; Colombo MP; Sensi ML; Cernuschi A; Parmiani G
    Int J Cancer; 1983 Apr; 31(4):483-9. PubMed ID: 6832855
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune response to sarcomas. A review.
    Weinert CR; McMaster JH; Ferguson RJ
    Clin Orthop Relat Res; 1974; (102):207-16. PubMed ID: 4529323
    [No Abstract]   [Full Text] [Related]  

  • 35. Specificity of in vivo tumor rejection assessed by mixing immune spleen cells with target and unrelated tumor cells.
    Röllinghoff M; Warner NL
    Proc Soc Exp Biol Med; 1973 Dec; 144(3):813-8. PubMed ID: 4543620
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparative effect of Mycobacterium bovis- and neuraminidase-treated tumor cells on the growth of established methylcholanthrene fibrosarcomas in syngeneic mice.
    Rios A; Simmons RL
    Cancer Res; 1972 Jan; 32(1):16-21. PubMed ID: 4550256
    [No Abstract]   [Full Text] [Related]  

  • 37. [Rejection of non viral tumors caused by infection with murine sarcoma virus].
    Basombrio MA
    Medicina (B Aires); 1977; 37(2):127-32. PubMed ID: 197370
    [No Abstract]   [Full Text] [Related]  

  • 38. Cell-mediated suppression of tumor immunity has a non-specific component. I. Evidence from transplantation tests.
    Hellström KE; Hellström I
    Int J Cancer; 1981; 27(4):481-5. PubMed ID: 6168591
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytolytic antibodies to methylcholanthrene-induced sarcomas elicited by immunization of syngeneic mice.
    Merino F; Abeyounis CJ; Milgrom F
    Eur J Cancer (1965); 1979 Jun; 15(6):829-35. PubMed ID: 499271
    [No Abstract]   [Full Text] [Related]  

  • 40. [Degranulation of the mast cells of syngeneic rats induced with sera of rats treated with grafts of methylcholanthrene-induced sarcoma].
    Laurentaci G; Chincoli S; Traficante A
    Minerva Chir; 1978 Oct; 33(19):1275-84. PubMed ID: 692910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.